medline.ch Respirationstrakt SARS

	Development of a Platform for in-situ Airborne Virus Detection by Interfacing RT-LAMP Assay with a Condensational Growth Collector. Aerosol Sci Technol Shirkhani A, Jansen M, Alipanahrostami M, Manzanas C, Shankar SN, Vass WB, Chien CH, Washeem M, O'Connor A, Lednicky JA, Fan ZH, Wu CY. PMID: 41918788 [PubMed]
	Exploring the timeline and network interplay of immune mediators in COVID-19 patients according to disease outcome. Front Immunol Guimarães GMC, Costa-Pereira C, Faustino RDS, Alves LS, Carvalho FR, Medeiros T, Brito-de-Sousa JP, Amaral LR, Peruhype-Magalhães V, Campi-Azevedo AC, Teixeira-Carvalho A, Silva AA, Martins-Filho OA. PMID: 41918757 [PubMed - indexed for MEDLINE]
	The cytokine signature in multiple sclerosis: a study during the SARS-CoV-2 pandemic. Front Immunol Puthenparampil M, Marin A, De Napoli F, Di Paola A, Mauceri AV, Ruggero S, Rinaldi F, Perini P, Viola A, Molon B, Gallo P. PMID: 41918744 [PubMed - indexed for MEDLINE]
	The impact of the COVID-19 pandemic on the epidemiology, clinical manifestations and molecular characteristics of Mycoplasma pneumoniae. Front Immunol Yan L, Fu H, Zhang H, Dong H, Chen J, Yu L, Zhang L. PMID: 41918740 [PubMed - indexed for MEDLINE]
	Lessons from irritable bowel syndrome: potential for understanding and managing post-COVID. Front Immunol Stallmach A, Layer P, Katzer K, Reuken PA. PMID: 41918727 [PubMed - indexed for MEDLINE]
	Spectrum of Non-SARS-CoV-2 Respiratory Viruses Among Symptomatic Post-COVID Adults in a North Indian Tertiary Care Center: A 2022 Surveillance Study. Cureus Roy M, Sarkar S, Sharma V, Bora I, Mohindra R, Padhy S, Sapra M, Mohi GK, Ratho RK. PMID: 41918665 [PubMed]
	The role of ivermectin in the prevention and treatment of SARS-CoV-2 infection: a meta-analysis of randomized controlled trials. BMC Infect Dis Wang X, Meng J, Li Y, Xiang Y, Wu Y, Xiong Y, Liu P, Gao S. PMID: 41918076 [PubMed - as supplied by publisher]
	Effectiveness, immunogenicity and safety of monovalent DS-5670a and bivalent DS-5670a/b SARS-CoV-2 vaccines: results from two randomized, active-comparator, non-inferiority trials. Commun Med (Lond) Hamada S, Suda M, Ishida K, Furihata K, Sogawa Y, Kumazaki M, Takahashi K, Sakakibara S, Matsunaga S, Jonai N, Nakayama T, Takeshita F. PMID: 41917439 [PubMed - as supplied by publisher]
	Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza Virus. Adv Exp Med Biol Ota M, Sano K, Yoshihara K, Watanabe S, Hasegawa H, Miyakawa K. PMID: 41917406 [PubMed - indexed for MEDLINE]
	Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the Curve. Clin Pharmacokinet Zhang H, Tang W, Sadow S, Baronio R, Tullio AN, Hirao L, Dzutseva V, Chen CC, Kiazand A, Chang LJ, Cohen TS, Gibbs M. PMID: 41917376 [PubMed - as supplied by publisher]
	Programmable kinetic barcoding for multiplexed RNA detection with Cas13a. Nat Biomed Eng Son S, Lyden A, Ng CF, Dextre A, Shu J, Stephens SI, Fozouni P, Knott GJ, Smock DCJ, Liu TY, Boehm D, Simoneau C, Kumar GR, Doudna JA, Ott M, Fletcher DA. PMID: 41917196 [PubMed - as supplied by publisher]
	Morphology-guided deep learning for nanoparticle agglomeration diagnostic assays. Sci Rep Jhawar K, Chu XL, DeGrandchamp JB, Yin Y, Peddibhotla LA, Banu S, Mohd Hatta FNN, Wang Y, Török P, Wang L. PMID: 41917119 [PubMed - as supplied by publisher]
	Peak Nasal SARS-CoV-2 and Influenza Viral Loads Relative to Symptom Onset, 2022-2025: Impact of Vaccination and Implications for Multiplexed Testing. J Infect Dis Hunt JH, Damhorst GL, Parsons R, Frediani JK, McLendon KB, Sullivan J, Westbrook AL, Lam WA, Martin GS, Pollock NR. PMID: 41916929 [PubMed - as supplied by publisher]
	A Phase I Single and Multiple Ascending Dose, Food Effect Study of the Safety, Tolerability and Pharmacokinetics of SAL0133 in Healthy Participants. Clin Ther He Q, Xie H, Mu S, Zhang R, Lin W, Zhang L, Ma J, Xie J, Chen R, Yang H. PMID: 41916795 [PubMed - as supplied by publisher]
	De-implementation of healthcare interventions post-COVID-19: evidence from the Evidence-Based Interventions (EBI) programme in England. BMJ Open Glynn J, Jones T, Bell M, Blazeby JM, Burton C, Conefrey C, Donovan J, Farrar N, Morley J, McNair AG, Owen-Smith A, Rule E, Thornton G, Tucker V, Williams I, Rooshenas L, Hollingworth W. PMID: 41916633 [PubMed - indexed for MEDLINE]
	Descriptive analysis of interns' basic psychological needs, burnout and empathy in the COVID-19 pandemic in Ireland. BMJ Open Patterson A, Brady C, Burke E, Castello S, Courtney L, F Curley G, Donnelly S, Hennessy M, McLoughlin DM, O'Connell F, Roberts TE, Ten Cate O, Wald H, Zgaga L. PMID: 41916621 [PubMed - indexed for MEDLINE]
	Projecting excess mortality due to infectious diseases during a crisis: methods and application to the Gaza Strip, 2023-2024. J R Soc Interface Checchi F, Barnsley G, Jamaluddine Z, Abukmail H, Chen Z, Igusa T, Spiegel PB, Majorin F. PMID: 41916604 [PubMed - indexed for MEDLINE]
	Tracking resurgence of SARS-CoV-2 in Shenzhen, China, 2023-2025: evidence from wastewater, clinical, and climatic data. Environ Int Wei B, Du C, Lv Z, Fu Y, Cheng Y, Zhang Z, Du Z, Peng Z, Xu H, Shi X, Wu Z, Huang X, Yang P, Yang X, Luo G, Huang D, Guo B, Huang T, Li Y, Zhu B, Hu Q. PMID: 41916164 [PubMed - as supplied by publisher]
	Molecular epidemiology and antifungal susceptibility patterns of Aspergillus and Candida species isolated from Argentinian patients with COVID-19-associated pulmonary aspergillosis and candidemia. Rev Argent Microbiol Hermida Alava K, de Abreu M, Posse GB, López Moral L, Valdez R, Chacón Y, Maldonado I, Mendiondo N, Aguilar AP, Nusblat AD, García Effrón G, Cuestas ML. PMID: 41916068 [PubMed - as supplied by publisher]
	Discovery of 3-phenyl-2H-aziridine derivatives as potent irreversible inhibitors of SARS-CoV-2 main protease via enzyme kinetics and microscale thermophoresis. Bioorg Chem Wang X, Zhang M, Chen L, Yu W, Chang X, Wang R. PMID: 41916037 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 285875

Seite 1 von 14294



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung